Geron Corporation - Common Stock - fluxo de caixa (NASDAQ:GERN)

Financials

Fluxo de caixa operacional -66.65 M-95.56 M-127.38 M-167.74 M-218.62 M-111.04 M -125.96 M Fluxo de caixa de investimento -105.32 M71.95 M62.07 M-180.32 M-106 M107.25 M 106.66 M Fluxo de caixa de financiamento 168.35 M48.56 M87.26 M362.02 M334.37 M2.27 M 4.44 M Fluxo de caixa livre -66.65 M-95.56 M-127.38 M-167.74 M-218.62 M-111.04 M -125.96 M

Geron Corporation - Common Stock

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

GERN

Financials

Geron Corporation - Common Stock

Notícias

Geron (GERN) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Geron Corporation (GERN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Geron reporta crescimento de receita no 1º tri de 2026 e ação sobe

Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates

Geron nomeia Patricia S. Andrews e Constantine Chinoporos para o conselho de administração

Geron na Conferência de Saúde da Barclays: crescimento estratégico e planos futuros

Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans

Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?

Geron na TD Cowen: crescimento estratégico e expansão de mercado

Geron at TD Cowen: Strategic Growth and Market Expansion

Geron: Why I'm Doubling Down On My 'Sell' Rating After Q4 Earnings (NASDAQ:GERN)